NovoCure Ltd (NVCR): R&D Expense
$224.54M
Year ended 2025-12-31
$224.72M
Trailing 12 months to 2026-06-30
+2.9%
3-year compound annual growth
+11.2%
5-year compound annual growth
+17.8%
10-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $224.54M | +7.1% | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | $209.65M | -6.0% | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | $223.06M | +8.2% | 2026-02-26, From 2023-01-01 |
| 2022-12-31 | $206.09M | +2.4% | 2025-02-27, From 2022-01-01 |
| 2021-12-31 | $201.30M | +52.5% | 2024-02-22, From 2021-01-01 |
| 2020-12-31 | $132.01M | +67.1% | 2023-02-23, From 2020-01-01 |
| 2019-12-31 | $79.00M | +56.2% | 2022-02-24, From 2019-01-01 |
| 2018-12-31 | $50.57M | +32.7% | 2021-02-25, From 2018-01-01 |
| 2017-12-31 | $38.10M | -8.1% | 2020-02-27, From 2017-01-01 |
| 2016-12-31 | $41.47M | -5.2% | 2019-02-28, From 2016-01-01 |
| 2015-12-31 | $43.75M | +8.3% | 2018-02-22, From 2015-01-01 |
| 2014-12-31 | $40.38M | +16.0% | 2017-02-23, From 2014-01-01 |
| 2013-12-31 | $34.80M | n/a | 2016-03-01, From 2013-01-01 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| NovoCure Ltd (NVCR) | 2025-12-31 | $224.54M | +7.1% |
| UFP Technologies Inc (UFPT) | 2025-12-31 | $8.60M | -17.3% |
| iRhythm Holdings, Inc. (IRTC) | 2025-12-31 | $84.61M | +18.4% |
| Bioventus Inc. (BVS) | 2025-12-31 | $12.11M | -13.2% |
| Alphatec Holdings, Inc. (ATEC) | 2025-12-31 | $76.27M | -5.5% |
| AtriCure, Inc. (ATRC) | 2025-12-31 | $99.21M | +3.2% |
| Orthofix Medical Inc. (OFIX) | 2025-12-31 | $65.85M | -10.6% |
| Glaukos Corp (GKOS) | 2025-12-31 | $150.61M | +10.4% |
| Inspire Medical Systems, Inc. (INSP) | 2025-12-31 | $103.17M | -9.6% |
Compare NVCR, UFPT, IRTC, BVS side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗